Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hojjat-Farsangi, Mohammad  [Clear All Filters]
2023
Maleki F, Razmi H, Rashidi M-R, Yousefi M, Ramazani S, Ghorbani M, Hojjat-Farsangi M, Shahpasand K. Detection of receptor tyrosine kinase-orphan receptor-2 using an electrochemical immunosensor modified with electrospun nanofibers comprising polyvinylpyrrolidone, soy, and gold nanoparticles. Mikrochim Acta. 2023;190(10):418.
2022
Yousefzadeh Y, Soltani-Zangbar MSadegh, Kalafi L, Tarbiat A, Farid SShahmohamm, Aghebati-Maleki L, Parhizkar F, Danaii S, Taghavi S, Jadidi-Niaragh F, et al. Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women. Mol Biol Rep. 2022.
2021
Motavalli R, Etemadi J, Soltani-Zangbar MSadegh, Ardalan M-R, Kahroba H, Roshangar L, Nouri M, Aghebati-Maleki L, Khiavi FMotavalli, Abediazar S, et al. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine. 2021;141:155452.
Kiani FKaroon, Izadi S, Dezfouli EAnsari, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MMortazavi, Esfahani MNasr, Karpisheh V, Khesht AMahmoud Sa, et al. Simultaneous silencing of A2aR and PD-1 as immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sci. 2021:120166.
2020
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MReza, Jadidi-Niaragh F. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915.
Gholipour E, Sarvarian P, Samadi P, Talebi M, Movassaghpour A, Motavalli R, Hojjat-Farsangi M, Yousefi M. Exosome: From leukemia progression to a novel therapeutic approach in leukemia treatment. Biofactors. 2020.
Danaii S, Ghorbani F, Ahmadi M, Abbaszadeh H, Koushaeian L, Soltani-Zangbar MSadegh, Mehdizadeh A, Hojjat-Farsangi M, Kafil HSamadi, Aghebati-Maleki L, et al. IL-10-producing B cells play important role in the pathogenesis of recurrent pregnancy loss. Int Immunopharmacol. 2020;87:106806.
Pourmoghadam Z, Soltani-Zangbar MSadegh, Sheikhansari G, Azizi R, Eghbal-Fard S, Mohammadi H, Siahmansouri H, Aghebati-Maleki L, Danaii S, Mehdizadeh A, et al. Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study. J Reprod Immunol. 2020;142:103182.
Hashemi V, Farhadi S, Chaleshtari MGhasemi, Seashore-Ludlow B, Masjedi A, Hojjat-Farsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, et al. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int Immunopharmacol. 2020;83:106446.
Masjedi A, Ahmadi A, Atyabi F, Farhadi S, Irandoust M, Khazaei-Poul Y, Chaleshtari MGhasemi, Fathabad MEdalati, Baghaei M, Haghnavaz N, et al. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020.
2019
Hassannia H, Chaleshtari MGhasemi, Atyabi F, Nosouhian M, Masjedi A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H, Ghalamfarsa G, et al. Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine. Immunology. 2019.
2018
Eghbal-Fard S, Yousefi M, Heydarlou H, Ahmadi M, Taghavi S, Movasaghpour A, Jadidi-Niaragh F, Yousefi B, Dolati S, Hojjat-Farsangi M, et al. The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2018.